Perreau et al. and others reported that HGF expression levels could predict the severity of COVID-19 and that HGF could contribute to alleviating lung injury by suppressing the transforming growth factor-beta (TGF-β) signaling pathway [101–103]. The gene discussed is TGFB1; the disease is COVID-19.